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After an outbreak of meningococcal disease caused by
Neisseria meningitidis W135, associated with the Hajj pilgrim-
age in 2001, 15% of returning vaccinated pilgrims carried a sin-
gle W135 clone, and 55% were still carriers 6 months later.
Transmission to 8% of their unvaccinated household contacts
occurred within the first few weeks, but no late transmission
took place. Public health interventions are needed to protect
household contacts.
he annual Islamic pilgrimage to Mecca and Medina in
Saudi Arabia (Hajj pilgrimage) attracts approximately 2
million pilgrims from all over the world. Overcrowding during
the 1-month-long religious rituals may facilitate rapid dissemi-
nation of meningococci (1–3). An international outbreak of
meningococcal disease caused by Neisseria meningitidis
W135 occurred in association with the Hajj pilgrimage in 2000
and 2001 (4,5), with a high attack rate not only among the pil-
grims but also among household contacts of returning pilgrims
(6–10). 
Meningococcal carriers are the primary source of N. men-
ingitidis transmission (11). Although vaccination can protect
pilgrims against invasive meningococcal disease, it does not
prevent acquisition of carriage (12). Pilgrims returning from
the Hajj may have a high meningococcal carriage rate (13),
and after the W135 outbreak during the Hajj pilgrimage 2001,
we documented a high acquisition rate of a single clone of
W135 in pilgrims (14). Returning pilgrims may therefore
spread the organism to household contacts or even to the com-
munity at large. 
Although researchers have shown that W135 can attain a
high carriage rate (14,15), no data are available on the duration
of carriage of W135. Persistence of carriage may represent a
threat to the community and has important public health impli-
cations. We set out to determine the persistence of W135 men-
ingococcal carriage in pilgrims and to quantify the ongoing
risk of transmission to household contacts. 
Methods
Vaccination records kept at a Moslem center in Singapore
were reviewed to identify pilgrims on the Hajj pilgrimage in
2001. Returning pilgrims, all of whom had received pre-Hajj
quadrivalent meningococcal polysaccharide vaccine, were
contacted and invited to participate in the study.
Tonsillopharyngeal swabs specimens were taken from
returning Hajj pilgrims 2 weeks after the Hajj pilgrimage
2001, and those found to be carriers of the W135 clone (hence-
forth referred to as “pilgrim carriers”) had a repeat swab taken
5–6 months later. Antibiotics were not routinely administered
to those who were identified as carriers, although some took
antibiotics for other indications during the follow-up.
All household contacts of pilgrim carriers were asked to
come for a throat swab within the first month and 5–6 months
after the Hajj. In addition, all household contacts whose results
of the initial throat swab were negative were asked to return
for serial throat swabs taken 2 weeks, 1–2 months, and 2–3
months later.
Swab samples were transferred to a plate of selective cul-
ture medium (Oxoid GC, Basingstoke, U.K.). Culture plates
were immediately put in candle jars and transferred to the lab-
oratory within 2–4 hours of collection. Serogrouping by latex
agglutination (Murex, Dartford, U.K.)  and pulsed-field gel
electrophoresis (PFGE) was performed on all meningococcal
isolates. PFGE was performed by using previously described
methods (16). The Tenover criteria were used to interpret the
pattern of bands (17). 
All subjects gave written informed consent. The study was
approved by the Ethics Committee of Tan Tock Seng Hospital. 
Results
Swab specimens were taken from 373 Malay pilgrims at a
median time of 26 days (range 3–45) after return from the
Hajj. The median age was 47 years (range 3–78 years), and
57% were female. Of the 373, a total of 61 (16%) were found
to be meningococcal carriers (95% confidence interval [CI]
13% to 21%). Of these 61, 56 (92%) were of a single W135
clone by PFGE. Fifteen percent (95% CI: 12% to 19%) of the
returning pilgrims were carriers of the W135 clone (Table).
Forty pilgrim carriers returned for a repeat swab at 5–6 months
(range 144–182 days) after the Hajj. Of those 40, 22 (55%)
remained carriers of the W135 clone. 
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The household contacts of 42 of the pilgrim carriers (75%)
agreed to provide throat swabs specimens. Swabs were taken
from 117 (84%) of all existing 139 household contacts at a
median time of 32 (range 5–45) days after the Hajj. The median
age of household contacts was 14 years (range 1–52 years), and
65.3% were children <18 years of age. Of the 117 contacts, 13
(11%) were meningococcal carriers, and of those carriers 9
(69%) were found to carry the W135 clone (hereafter referred
to as “contact carriers”). The 9 contact carriers belonged to
eight households, and 11 (19%) of the pilgrim carriers transmit-
ted the W135 clone to at least one household contact. 
Of the 104 contacts with initially negative results, 26 had a
repeat swab specimen taken at a median interval of 15 days
(range 11–27 days) after the initial swab within the first month
after the Hajj, and all results continued to be negative. Thirty-
one of the 104 persons had repeat swabs taken at 1–2 months
(median of 39 days, range 30–60), 32 at 2–3 months (median
65 days, range 62–72), and 79 at 5–6 months (median 160
days, range 144–182) after the Hajj, and none was found to
have become a carrier (Figure).
Discussion
The high meningococcal carriage rate in returning pilgrims
is consistent with the rate of serogroup A meningococcal
infection found in pilgrims returning to the United States after
the 1987 Hajj (13). This rate is also in keeping with studies in
other situations in which large numbers of previously unre-
lated persons have come into close social contact (e.g., univer-
sity freshmen), and dramatic increases in carriage rate have
been shown to occur in the space of just a few days (18,19).
However, the carriage rate of 16% in this study is markedly
higher than the 2.6% found in pilgrims returning to the United
States after the 2001 Hajj (20). This discrepancy is unlikely to
be explained by differences in study methodology alone but
probably results from differences in living conditions, degree
of overcrowding, or social activities during the Hajj. Further
detailed epidemiologic studies are warranted to determine
exactly which aspect of the pilgrimage is responsible for the
high transmission that we have documented. The proportion of
overall carriage attributable to this single W135 clone (92% of
all carriage) in our study is unusual. Even in the situation of a
meningitis outbreak, the proportion of carriage of the hypervir-
ulent strain responsible for invasive disease rarely exceeds the
overall proportion of carriage in the population by a few per-
centage points (11,21,22). 
In addition to our findings that W135 can attain a high car-
riage rate, we have shown that duration of carriage with this
strain is lengthy (55% of carriers remain positive after 5–6
months). This long duration of carriage indicates that returning
pilgrims may represent an ongoing threat to the community. 
To our knowledge, this study is the first to investigate the
extent of early transmission of N. meningitidis from pilgrim
carriers to household contacts. We found that returning pil-
grims carrying the W135 clone transmitted it to 7.7% of their
household contacts, which is of the same order of magnitude
as the transmission rate of meningococcal carriage from
patients with invasive disease to household contacts (23,24).
However, acquisition occurred only in the first month of con-
tact with the returning pilgrim carriers, and none of the con-
tacts with initially negative results acquired the strain after
months of exposure. The absence of late transmission is an
important new finding for which the explanation is currently
unclear. Possibilities include the absence of particular epide-
miologic risk factors for transmission in contacts with persis-
tently negative results, host protective factors, or the
attenuated virulence of the organism in the pilgrim carrier over
time. Further studies are warranted to investigate our findings. 
The absence of late transmission in our cohort is also con-
sistent with our national epidemiologic data, which showed
Table. Meningococcal carriage rates in returning Hajj pilgrims and 





Household contacts of 
pilgrim carriersa
(n=373) (%) (n=117) (%)
Overall 61 (16.4) 13 (11.1)
W135 clone  56 (15.0) 9 (7.7)
aA pilgrim carrier is a returning pilgrim with tonsillopharyngeal carriage of the W135 
clone.
Figure. Results of serial tonsillopharyngeal swab
specimens from returning Hajj pilgrims and their
household contacts. A pilgrim carrier is a returning
pilgrim with tonsillopharyngeal carriage of the
W135 clone; a contact carrier is a household con-
tact of a pilgrim carrier and carries the W135
clone.Emerging Infectious Diseases  •  Vol. 9, No. 1, January 2003 125
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that all the cases of invasive W135 meningococcal disease in
contacts of returning Hajj pilgrims occurred within 2 months
after the end of the Hajj pilgrimage 2001 and no further cases
occurred later in the year (10,25). However, although persis-
tence of carriage appears not to put the household contact at
risk, this persistence may be an important threat to the commu-
nity at large. Cases of W135 disease were identified in the
United Kingdom several months after the end of the Hajj, but
most of these case-patients had no identifiable direct contact
with Hajj pilgrims (26). 
Although vaccination may protect the pilgrims from inva-
sive disease, our data show that returning pilgrims represent a
sizeable reservoir of a highly transmissible and persistent
W135 clone, which places their unvaccinated family contacts
(and possibly the community at large) at risk of invasive dis-
ease. The appropriate public health response to this problem is
unclear. One approach would be to eradicate carriage in pil-
grims by administering antibiotics at the point of return to their
home countries. However, more data on the impact of this
intervention and on resistance and safety issues are needed
before embarking on such a large-scale program. Vaccination
of household contacts is a potential strategy, but it would be
expensive and difficult to implement. Increasing the uptake of
the quadrivalent meningococcal vaccine (now mandatory for
all pilgrims) may have a beneficial effect in decreasing the car-
riage of W135 (6). Although the vaccine did not prevent
acquisition of carriage in our cohort of Singaporean pilgrims,
it may have a greater effect when the entire Hajj pilgrim popu-
lation is vaccinated. Future studies are essential in order to
determine the public health impact of such a vaccination pro-
gram.
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